Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
PLoS One. 2022 Dec 1;17(12):e0278038. doi: 10.1371/journal.pone.0278038. eCollection 2022.
To evaluate the prognostic impact of lymph node dissection (LND) in patients who underwent radical nephroureterectomy (RNU) with bladder cuff excision (BCE) for clinically node-negative (cN0) upper urinary tract urothelial carcinoma (UTUC).
We retrospectively enrolled 520 patients with cN0 UTUC in a single tertiary referral center from 2000 to 2015. The patients were divided into three groups: patients with and without pathologically proved lymph node metastasis (pN1-3 and pN0, respectively) and patients without LND (pNx). We analyzed associations between overall survival (OS)/ disease-free survival (DFS)/ cancer-specific survival (CSS) and clinical characteristics.
The patients were divided into three groups (pN1-3, pN0 and pNx with 20, 303, and 197 patients, respectively). OS/DFS/CSS in the pN1-3 group were significantly worse (all p<0.001) compared with the pN0 group. However, there were no significant differences between the pNx and pN0 groups. In the multivariate analyses, CSS was only affected by age [(hazard ratio (HR) = 1.03, p = 0.008]), positive surgical margin (HR = 3.38, p<0.001) and pathological T3-4 stages (HR = 4.07, p<0.001). In the subgroup analyses for patients with LND, locally advanced disease (pT3 and pT4) had significantly more metastases [T3-4: 13.91% (16/115) vs. T0-2: 1.92% (4/208), p<0.001].
In the pN0 group, LND for cN0 UTUC did not show therapeutic benefits in terms of DFS, CSS, and OS. However, LND with RNU allowed optimal tumor staging, through patients still had a poor prognosis. Clinically occult LN metastases were found in 6.2% of our patients.
评估行根治性肾输尿管切除术(RNU)加膀胱袖状切除术(BCE)治疗临床淋巴结阴性(cN0)上尿路上皮癌(UTUC)患者中淋巴结清扫术(LND)的预后影响。
我们回顾性纳入 2000 年至 2015 年在一家单中心三级转诊中心接受治疗的 520 例 cN0 UTUC 患者。患者分为三组:病理证实有淋巴结转移(pN1-3)和无淋巴结转移(pN0),以及未行 LND(pNx)。我们分析了总生存(OS)/无病生存(DFS)/癌症特异性生存(CSS)与临床特征之间的关系。
患者分为三组(pN1-3、pN0 和 pNx,分别为 20、303 和 197 例)。pN1-3 组的 OS/DFS/CSS 明显较差(均 p<0.001),与 pN0 组相比。然而,pNx 与 pN0 组之间无显著差异。在多变量分析中,仅年龄(HR=1.03,p=0.008)、阳性切缘(HR=3.38,p<0.001)和病理 T3-4 期(HR=4.07,p<0.001)影响 CSS。在 LND 患者的亚组分析中,局部晚期疾病(pT3 和 pT4)转移的发生率明显更高[T3-4:13.91%(16/115)比 T0-2:1.92%(4/208),p<0.001]。
在 pN0 组中,cN0 UTUC 的 LND 在 DFS、CSS 和 OS 方面没有显示出治疗益处。然而,LND 联合 RNU 可以进行最佳肿瘤分期,尽管患者的预后仍然较差。我们的患者中有 6.2%存在临床隐匿性淋巴结转移。